| Literature DB >> 31288152 |
Rui-Hua Zhang1, Hong-Liang Zhang2, Pei-Yao Li3, Jing-Ping Gao3, Qiang Luo3, Ting Liang3, Xue-Jing Wang4, Yong-Qing Hao5, Tong Xu6, Chun-Hong Li3, Cun-Lian Wang3, Hui-Chen Zhang7, Ming-Ju Xu3, Shu-Fei Tian3.
Abstract
Influenza A virus usually leads to economic loss to breeding farms and pose a serious threat to human health. Virus infecting tissues directly and influenza virus-induced excessive production of inflammatory factors play the key role in pathogenesis of the disease, but the mechanism is not well clarified. Here, the role of autophagy was investigated in H9N2 influenza virus-triggered inflammation. The results showed that autophagy was induced by H9N2 virus in A549 cells and in mice. Inhibiting autophagy by an autophagy inhibitor (3-methyladenine, 3-MA) or knockdown of Atg5(autophagy-related gene) by Atg5 siRNA significantly suppressed H9N2 virus replication, H9N2 virus-triggered inflammatory cytokines and chemokines, including IL-1β, TNF-α, IL-8, and CCL5 in vitro and in vivo, and suppressed H9N2 virus-triggered acute lung injury as indicated as accumulative mortality of mice, inflammatory cellular infiltrate and interstitial edema, thickening of the alveolar walls in mice lung tissues, increased inflammatory cytokines and chemokines, increased W/D ratio in mice. Moreover, autophagy mediated inflammatory responses through Akt-mTOR, NF-κB and MAPKs signaling pathways. Our data showed that autophagy was essential in H9N2 influenza virus-triggered inflammatory responses, and autophagy could be target to treat influenza virus-caused lung inflammation.Entities:
Keywords: Acute lung injury; Autophagy; H9N2 influenza virus
Mesh:
Substances:
Year: 2019 PMID: 31288152 DOI: 10.1016/j.intimp.2019.105737
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932